Following Joko Widodo’s presidency, Indonesia entered a new era of leadership under President Prabowo Subianto. New health and economic direction and priorities will impact the medical device industry’s operations in Indonesia.
Produced by Speyside for APACMed, this report analyses the implications of policy changes put forth during the first 100 days of Prabowo’s administration, localization and procurement policy, and a mapping of key governmental stakeholders according to their priorities and motivations.

Access limited to APACMed members only
Access limited to APACMed members only